Coverage Status
All 50 states and DC are available on FormCheckRx. Michigan is fully verified by a licensed PharmD against the official SPDL. All other states are in active beta — results are available but should be verified against the applicable plan PBM for critical coverage decisions until PharmD verification is complete.
| State | Status | PDL Structure | MCOs | PDL Update Frequency | Notes |
|---|---|---|---|---|---|
| Michigan | Verified | Single PDL (SPDL) | 11 | Monthly off-cycle updates | 2025–2026 SPDL — fully validated |
| Alabama | Beta | MCO-individual | 4 | Quarterly | |
| Alaska | Beta | FFS + Managed Care | 2 | Quarterly | |
| Arizona | Beta | MCO-individual | 6 | Quarterly | |
| Arkansas | Beta | State-directed PDL | 3 | Quarterly | |
| California | Beta | FFS carve-out (2022) | 22 | Monthly | Pharmacy benefit carved out of MCOs |
| Colorado | Beta | MCO-individual | 5 | Quarterly | |
| Connecticut | Beta | MCO-individual | 3 | Quarterly | |
| Delaware | Beta | MCO-individual | 3 | Quarterly | |
| District of Columbia | Beta | MCO-individual | 3 | Quarterly | |
| Florida | Beta | State PDL (AHCA P&T) | 10 | Quarterly (P&T) | Next update Apr 1, 2026 |
| Georgia | Beta | MCO-individual | 6 | Quarterly | |
| Hawaii | Beta | MCO-individual | 2 | Quarterly | |
| Idaho | Beta | State PDL | 2 | Quarterly | |
| Illinois | Beta | MCO-individual | 8 | Quarterly | |
| Indiana | Beta | MCO-individual | 4 | Quarterly | |
| Iowa | Beta | MCO-individual | 3 | Quarterly | |
| Kansas | Beta | MCO-individual | 3 | Quarterly | |
| Kentucky | Beta | Single PBM (SPBM) | 5 | Monthly | State-directed single PBM model |
| Louisiana | Beta | Single PBM (SPBM) | 5 | Monthly | State-directed single PBM model |
| Maine | Beta | MCO-individual | 2 | Quarterly | |
| Maryland | Beta | MCO-individual | 5 | Quarterly | |
| Massachusetts | Beta | MCO-individual | 4 | Quarterly | |
| Minnesota | Beta | MCO-individual | 6 | Quarterly | |
| Mississippi | Beta | Universal PDL (SSDC) | 4 | Monthly | Sovereign States Drug Consortium |
| Missouri | Beta | FFS carve-out | 3 | Quarterly | |
| Montana | Beta | FFS + MCO | 2 | Quarterly | |
| Nebraska | Beta | MCO-individual | 3 | Quarterly | |
| Nevada | Beta | MCO-individual | 3 | Quarterly | |
| New Hampshire | Beta | MCO-individual | 3 | Quarterly | |
| New Jersey | Beta | MCO-individual | 5 | Quarterly | |
| New Mexico | Beta | MCO-individual | 4 | Quarterly | |
| New York | Beta | FFS carve-out (NYRx) | 8 | Monthly | NYRx state pharmacy program |
| North Carolina | Beta | State PDL (P&T) | 5 | Quarterly + off-cycle | GLP-1 changes Oct–Dec 2025 |
| North Dakota | Beta | FFS + MCO | 2 | Quarterly | |
| Ohio | Beta | Single PBM (SPBM) | 5 | Monthly | ODM drug lookup tool available |
| Oklahoma | Beta | State PDL | 4 | Quarterly | |
| Oregon | Beta | MCO-individual | 5 | Quarterly | |
| Pennsylvania | Beta | Statewide PDL (DHS P&T) | 7 | Annual + off-cycle | HealthChoices + CHC MCOs |
| Rhode Island | Beta | MCO-individual | 2 | Quarterly | |
| South Carolina | Beta | Single PDL (Jul 2024) | 5 | Quarterly | SCDHHS unified PDL effective Jul 2024 |
| South Dakota | Beta | State PDL | 2 | Quarterly | |
| Tennessee | Beta | FFS carve-out | 4 | Quarterly | |
| Texas | Beta | State PDL (VDP) | 20 | Monthly | Texas Vendor Drug Program; MCOs required to follow |
| Utah | Beta | MCO-individual | 3 | Quarterly | |
| Vermont | Beta | State PDL | 1 | Quarterly | |
| Virginia | Beta | MCO-individual | 6 | Quarterly | |
| Washington | Beta | MCO-individual | 4 | Quarterly | |
| West Virginia | Beta | FFS carve-out | 3 | Quarterly | |
| Wisconsin | Beta | FFS carve-out | 4 | Quarterly | |
| Wyoming | Beta | FFS + MCO | 2 | Quarterly |